BDBM700108 US20240335569, Compound 3BP-2929

SMILES OC(=O)CN1CCN(CC(O)=O)CCN(CC(=O)N2CCN(CCCOc3ccc4nccc(C(=O)NCC(=O)N5CC(F)(F)C[C@H]5C#N)c4c3)CC2)CCN(CC(O)=O)CC1

InChI Key InChIKey=ICWDAESAANBIGG-UHFFFAOYSA-N

Data  1 KI  6 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 7 hits for monomerid = 700108   

TargetDipeptidyl peptidase 4(Human)
3 B Pharmaceuticals

US Patent
LigandPNGBDBM700108(US20240335569, Compound 3BP-2929)
Affinity DataIC50: 1.00E+3nMAssay Description:PREP activity was measured with recombinant human PREP (R&D systems, #4308-SE). The PREP activity assay was performed using the FACS buffer (PBS incl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/10/2025
Entry Details
Go to US Patent

TargetPresequence protease, mitochondrial(Human)
3 B Pharmaceuticals

US Patent
LigandPNGBDBM700108(US20240335569, Compound 3BP-2929)
Affinity DataIC50: 1.00E+3nMAssay Description:PREP activity was measured with recombinant human PREP (R&D systems, #4308-SE). The PREP activity assay was performed using the FACS buffer (PBS incl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/10/2025
Entry Details
Go to US Patent

TargetProlyl endopeptidase FAP(Mouse)
3 B Pharmaceuticals

US Patent
LigandPNGBDBM700108(US20240335569, Compound 3BP-2929)
Affinity DataIC50: 1.58nMAssay Description:Recombinant mouse FAP (R&D systems, #8647-SE) was diluted in assay buffer (50 mM Tris, 1 M NaCl, 1 mg/mL BSA, pH 7.5) to a concentration of 3.6 nM. 2...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/10/2025
Entry Details
Go to US Patent

TargetDipeptidyl peptidase 4(Human)
3 B Pharmaceuticals

US Patent
LigandPNGBDBM700108(US20240335569, Compound 3BP-2929)
Affinity DataIC50: 8.81E+3nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/11/2025
Entry Details
Go to US Patent

TargetPresequence protease, mitochondrial(Human)
3 B Pharmaceuticals

US Patent
LigandPNGBDBM700108(US20240335569, Compound 3BP-2929)
Affinity DataIC50: 796nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/11/2025
Entry Details
Go to US Patent

TargetProlyl endopeptidase FAP(Human)
The Johns Hopkins University

US Patent
LigandPNGBDBM700108(US20240335569, Compound 3BP-2929)
Affinity DataIC50: 0.75nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/11/2025
Entry Details
Go to US Patent

TargetProlyl endopeptidase FAP(Human)
The Johns Hopkins University

US Patent
LigandPNGBDBM700108(US20240335569, Compound 3BP-2929)
Affinity DataKi:  0.150nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/11/2025
Entry Details
Go to US Patent